Abstract | During mammalian embryonic development, a single fertilized egg cell will proliferate and differentiate into all the cell lineages and cell types that eventually form the adult organism. Cell lineage diversification involves repeated cell fate choices that ultimately occur at the level of the individual cell rather than at the cell-population level. Improvements in single-cell technologies are transforming our understanding of mammalian development, not only by overcoming the limitations presented by the extremely low cell numbers of early embryos but also by enabling the study of cell fate specification in greater detail. In this Review , we first discuss recent advances in single-cell transcriptomics and imaging and provide a brief outline of current bioinformatics methods available to analyse the resulting data. We then discuss how these techniques have contributed to our understanding of pre-implantation and early postimplantation development and of in vitro pluripotency. Finally , we overview the current challenges facing single-cell research and highlight the latest advances and potential future avenues. . This targeted analysis of known genes has been instrumental in characterizing molecular programmes of multilineage cell progenitors, which seem to co-express genes characteristic of the different mature cell types they will give rise to 7, 8 . It is also essential for the study of specific signalling pathways or transcription factor networks in developmental cell populations, ranging from the zygote to the differentiation of particular cell lineages, such as blood or endothelial cells 6, 9, 10 . Nonetheless, to identify novel factors and signalling pathways at play during embryonic development, genome-wide transcriptomics approaches are required.
During the early stages of mammalian embryonic development, the fertilized egg will give rise to all the cell types that form the adult organism through sequential rounds of proliferation and differentiation. The robustness of this process indicates that development is governed by a set of principles that guide each cell to commit to becoming a particular cell type. But what are these principles? How do cells consistently activate certain molecular programmes and not others? There has been extensive research to try to decipher these principles by assessing how genes regulate each other. Conventional experimental approaches, however, required large homogeneous cell populations and were therefore not applicable to the early mammalian embryo, which is composed of very few cells that become increasingly heterogeneous as the embryo develops.
With the advent of high-throughput single-cell sequencing and single-molecule imaging technologies, it is now possible to generate single-cell molecular profiles on a large scale and to quantify single-cell gene expression more accurately in defined multicellular tissues. Because cell fate decisions are ultimately made by individual cells responding to external stimuli, these new transcriptional technologies are now making a great impact on our understanding of early embryonic development.
In this Review, we summarize the recent advances in single-cell transcriptional technologies with a particular focus on single-cell transcriptomics and imaging and provide a brief outline of the current bioinformatics methods to analyse the resulting data. We then focus on how these techniques have contributed to our understanding of in vivo pre-implantation and early post-implantation mouse development and of in vitro pluripotency. Finally, we overview the current challenges of using these technologies and highlight some future avenues for the field.
Single-cell technologies
One of the most important discoveries in the single-cell field was the finding that single cells from organs or cell types that were previously considered to be homogeneous are often functionally and molecularly heterogeneous. This initially became evident using flow cytometry, which is one of the first high-throughput single-cell analysis approaches that now permits the assessment of up to 40 cell-surface marker expression profiles in individual cells when combined with elemental mass spectrometry (reviewed in ref. 1 ). The establishment of fluorescence-activated cell sorting (FACS) has also enabled sorting individual cells, or molecularly defined cell populations, into single wells to evaluate them separately 2 . As outlined below, more recent technologies now permit the simultaneous measurement of many parameters of individual cells, which has contributed to Single-cell transcriptional profiling: a window into embryonic cell-type specification the discovery of novel regulators of cell differentiation and developmental processes.
Single-cell transcriptomics. Single-cell transcriptional analyses were pioneered with the amplification of polyadenylated RNA from individual haematopoietic cells to measure relative abundances between transcripts 3 . However, this was a qualitative approach, and it was not until the development of quantitative real-time PCR (qPCR) 4, 5 that single-cell qPCR (sc-qPCR) became feasible. Since then, considerable progress in the automation and development of microfluidics systems has enabled measuring the expression of several genes in several single cells in one qPCR run 6 . This targeted analysis of known genes has been instrumental in characterizing molecular programmes of multilineage cell progenitors, which seem to co-express genes characteristic of the different mature cell types they will give rise to 7, 8 . It is also essential for the study of specific signalling pathways or transcription factor networks in developmental cell populations, ranging from the zygote to the differentiation of particular cell lineages, such as blood or endothelial cells 6, 9, 10 . Nonetheless, to identify novel factors and signalling pathways at play during embryonic development, genome-wide transcriptomics approaches are required.
Transcriptomics technologies began with the development of single-cell microarrays to study gene expression in the mouse blastocyst 11 . Using this strategy, embryonic single cells were molecularly classified into two groups, epiblast and primitive endoderm, which are two lineages known to segregate at the blastocyst stage 11 (Box 1). Although microarrays could already distinguish between cells of different lineages, they are restricted to analysing characterized transcripts, from which the probes used to measure transcript abundances are derived.
The need for a more comprehensive tool led to the development of the first single-cell RNA-seq (scRNA-seq) protocol in 2009 (ref.
12
). This method was able to detect a considerably higher number of genes in blastocysts compared with single-cell microarrays and, therefore, a more thorough transcriptional characterization of this developmental stage could be achieved 12 . Since then, several optimized protocols have been developed, including Smart-seq2 and cell expression by linear amplification and sequencing 2 (CEL-seq2) [13] [14] [15] [16] (Box 2).
These improved methods achieve a higher transcript coverage compared with early scRNA-seq protocols and are considered the gold standard in the field. However, they still require the isolation of individual cells into single wells and are thus designated as well-based methods. Such methods utilize strategies, such as FACS or microdissection, which restrict cell throughput.
To transcriptionally characterize whole organs or embryonic stages at the single-cell level in a genomewide manner, droplet-based microfluidics protocols are a suitable alternative 17, 18 (Box 2). These enable the processing of thousands of cells in one experiment, thus contributing to the discovery of rare subpopulations within the sample or to the characterization of its molecular diversity. This methodology has recently been used to transcriptionally characterize several biological systems, such as adult retinal cell populations 18 , mouse embryonic stem cells (mESCs) 17 and the entire mouse embryo at day 8.25 of development (E8. 25) 19 . However, droplet-based techniques also have some limitations, such as the higher risk of generating data from cell doublets, a transcript coverage bias towards 3′ ends and being less sensitive than well-based methods owing to capturing fewer unique transcripts. Therefore, well-based methods remain a good choice for answering specific questions that require better transcriptome coverage and/or a relatively low cell number.
Regardless of which method is utilized (well-based or droplet-based), single-cell transcriptomics protocols require a pre-amplification step to obtain enough material for the downstream detection method, and, therefore, the raw data obtained in these methods reflect the relative abundances of the amplified cDNAs instead of the original amounts of RNAs in the sample. Since PCR amplification occurs in a nonlinear fashion, quantitative biases could be easily introduced in the resulting gene counts. Therefore, optimizing the number of PCR cycles in order to keep every reaction within the exponential phase by performing a preliminary set of tests can help reduce the risk of bias. Alternatively, a more precise method to quantify RNA reliably is the addition of molecular labels called unique molecular identifiers before amplifying the biological material 20 . By tagging each transcript individually, the absolute numbers of RNA molecules in each cell can be estimated, thus minimizing amplification noise.
Owing to the small amount of starting material, scRNA-seq data are prone to containing technical noise, which negatively correlates with transcript abundance 21 . Moreover, batch effects can confound both data analysis and display. These effects could be caused by several experimental conditions, ranging from using different reagent batches to performing the experiment on different days. To counteract these problems, normalization strategies and methods to bioinformatically infer the highly variable genes have been developed [21] [22] [23] [24] [25] . Once the raw sequencing counts are processed, current single-cell transcriptomics studies use dimensionality-reduction approaches, such as principal component analysis, t-distributed stochastic neighbour embedding (t-SNE) 26 and diffusion maps 27, 28 , to visualize the data ( fig. 1a) . In contrast to principal component analysis, t-SNE and diffusion maps are able to capture the nonlinear nature of biological processes; t-SNE is particularly useful for identifying the main transcriptionally defined cell groups that exist within the dataset. For instance, this strategy has been applied to resolve the biological structure of a scRNA-seq data set composed of cells collected during gastrulation (Box 1). This revealed the existence of ten distinct cell groups, which included populations of epiblast cells, mesoderm cells, blood and endothelial progenitor cells, and differentiated cells 29 . Importantly, the distances between the different groups visualized in t-SNE plots should not be considered a biological representation of relatedness. Coupled with cell clustering strategies, which help
Microfluidics systems
Automated technologies based on the use of microminiaturized devices for mixing and manipulating low fluid volumes aiming to achieve multiplexing and high-throughput yields. Epiblast group of cells derived from the inner cell mass that will give rise to the embryo proper.
Primitive endoderm
group of cells derived from the inner cell mass that contribute to extra-embryonic tissues such as the yolk sac.
Unique molecular identifiers
Short sequences that uniquely tag individual rNA molecules.
Dimensionality-reduction approaches
Methods used in highdimensional datasets, where each gene represents a dimension, to reduce the number of dimensions and elicit the visualization of the data set structure in a twodimensional or threedimensional plot.
reveal the prevalent gene expression profiles within the data set, t-SNE has enabled the transcriptional characterization of embryonic cell populations from single cells ranging between the early pre-implantation stages, gastrulation and organogenesis, as well as the transcriptional characterization of developing tissues, such as the heart and the blood 10, 19, [29] [30] [31] [32] . 
Box 1 | Mouse embryonic development
Fertilization gives rise to a totipotent cell, the zygote, which will generate all the embryonic and supportive extraembryonic tissues necessary for development. These processes start with the segregation of the embryonic and extra-embryonic lineages before the embryo implants into the uterus wall. once the embryo is implanted, the embryonic part will further diversify into the different cell types and organs that will form the adult organism.
Pre-implantation
Following fertilization, the zygote undergoes a series of symmetrical divisions until the 8-cell stage. The embryo then becomes compacted, and this aggregation of cells is termed the morula (see the figure, part a) . During the 8-to-16 and the 16-to-32-cell stage transitions, some cells will divide symmetrically and will become specified into the outer cell layer, called the trophectoderm (Te), which will contribute to the placenta; other cells will undergo asymmetric divisions, where one of the daughters will become the trophectoderm and the other will become part of the inner cell mass (ICm), which will give rise to the embryo proper. Following this first lineage specification, the ICm undergoes a second fate choice and becomes segregated into the epiblast (ePI) and the primitive endoderm (Pe) at the 32-to-64-cell stage, the latter giving rise to the yolk sac. At the same time, the embryo also undergoes a process of cavitation, and the blastocoel will form. Finally, at the blastocyst stage, spatial cell rearrangement gives rise to epiblast cells surrounded by outer primitive endoderm.
Post-implantation
Following implantation, which occurs at embryonic day 4.5 (e4.5), the embryo undergoes extensive proliferation coupled with morphogenetic cell movements. First, at e5.5, it adopts a cup-like shape (dashed rectangle; see the figure, part b), which is characteristic of mouse embryonic development. At this stage, the distal visceral endoderm becomes specified. The distal visceral endoderm is thought to be a signalling centre from which antagonists of the signalling factor Nodal, such as Cerberus (Cer) and left-right determination factor 1 (lefty1), are expressed and repress Nodal in the adjacent epiblast. Subsequently, through an ill-defined mechanism, the anterior visceral endoderm is specified at the anterior side of the embryo, which also secretes Nodal antagonists that seem to contribute to the formation of the primitive streak at the posterior side. During gastrulation, epiblast cells at the primitive streak undergo an epithelial-to-mesenchymal transition and become mesoderm, which then migrates out and colonizes the different regions of the embryo, including the extraembryonic yolk sac, and forms the allantois. The primitive streak extends distally as gastrulation progresses, and the cells that ingress later and more anteriorly are thought to become endoderm and colonize other tissues, such as the gut. In parallel, anterior epiblast cells adopt an ectodermal fate and will eventually form a portion of tissues such as the brain or the skin. During this developmental progression, the embryo also undergoes other morphological changes; particularly, the amnion and the chorion, two membranes that delimit the two embryonic cavities (the amniotic and the exocoelomic cavities, respectively) are formed. These analyses are used to infer a sequential progression by computationally ordering the cells along a coordinate that reflects the developmental path and, therefore, enable the study of gene expression dynamics along this trajectory. This approach has been applied to visualize the differentiation of many cell lineages, including those of blood cells 10, 28 , lymphoid cells 33, 35 and mESCs 9 , and helped to discover novel regulators of these processes. Importantly, pseudotime analyses assume that these biological processes are continuous and thus position cells that share a similar transcriptional profile close to each other along the developmental path. Consequently, they may not be accurate if the biological system behaves in an oscillatory manner or undergoes fast state transitions, thereby necessitating experimental validation. In such cases, previous knowledge of, for instance, specific genes known to have gradient expression along the trajectory of the studied process can help infer the developmental progression from snapshot data. This approach has recently been applied to predict genes with wave-like expression during mouse somitogenesis from cells at E8.25 and was subsequently validated using microdissection 19 .
High-throughput single-molecule imaging. A major limitation of single-cell transcriptomics is the lack of spatial and temporal resolution. Many studies have therefore used imaging technologies to understand how gene expression occurs and is orchestrated in single cells across a given tissue. Although imaging has generally been restricted by the number of transcripts one can assess owing to the limited range of discernible dyes, it is now possible to spatially resolve the expression of about 10 3 genes simultaneously in single cells using single-molecule RNA fluorescent in situ hybridization (sm-FISH) [36] [37] [38] . This is feasible owing to a combination of different sequence-specific probes that target each transcript multiple times, thus generating a unique transcript barcode, which can be resolved with microscopy ( fig. 1c ). sm-FISH has been applied in mESCs to describe their molecular heterogeneity 39 . This technique has also been used together with a CRISPR-Cas9 tool to establish a system called MEMOIR that records lineage information in single mESCs 40 . Importantly, sm-FISH is a targeted approach, which requires costly pre-designed probes to study all the genes of interest. Moreover, the technique currently requires bespoke imaging equipment and software, which, at least in the near future, will limit its use. Recently, a more indiscriminate strategy called fluorescent in situ sequencing (FISSEQ) has been established 41 , which enables unsupervised sequencing of single-cell transcripts in situ. However, its current detection limit of about 200 transcripts per cell and its high cost are considerable drawbacks.
The aforementioned methods provide temporal snapshots. Therefore, to validate the dynamics of a particular process, it is important to resort to live imaging techniques, which can track gene expression changes over time. In the past few years, major improvements enabled the detection of single molecules in living cells. For example, RNA can be labelled using the MS2 and PP7 systems, which consist of RNA hairpin sequences fused in tandem to the transcript of interest, and which are bound by a fluorescent protein with high specificity 42, 43 . However, in practice, most live imaging studies to date have used fluorescent reporters to track the changes in protein levels instead of transcript levels. This has produced controversial results regarding cell fate specification. For instance, gene regulation inferences from singlecell transcriptional studies in mice have suggested that during haematopoietic differentiation, the transcription factors Gata1 and Pu.1 are the master regulators of cell fate choice between the erythroid and myeloid lineages, respectively, by cross-repressing each other 44 . Recently, this model has been challenged by data obtained from tracking Gata1 and Pu.1 proteins using live imaging methods, which showed that Gata1 protein levels are independent of lineage specification 45 . This is a paradigmatic example of the importance of using complementary analysis approaches to validate the models inferred by single-cell transcriptomics studies. Following the normalization of gene expression data, visualization approaches (left), which are based on dimensionality-reduction techniques, and clustering (right) are applied to the data. Rows in the heat map depict single genes; columns refer to single cells; colours represent gene expression levels, where red is high and blue is low. Cells are clustered into groups A-C based on their gene expression profiles, and genes are grouped into groups X-Z based on their expression profiles. b | Pseudotime analysis. Pseudotime paths, which highlight the progression of the biological process, are inferred from the data set (top), and the dynamics of differentially expressed genes are analysed for each path (bottom). The top diagram is a visualization of the transcriptome data using diffusion maps and the paths that the pseudotime algorithm has inferred. The colour gradient seen in the arrows (from red to blue or to yellow) highlights progression from the starting cells (red) to the end cells (blue or yellow). The bottom diagrams show the different trends of gene expression along each of the paths. c | In single-molecule RNA fluorescent in situ hybridization (sm-FISH) labelling, a fluorophore-based barcode is assigned to a specific RNA sequence. In combinatorial labelling, each RNA transcript is targeted with multiple sequence-specific probes with different fluorophores (three in the example) that can be detected under the microscope using different channels. The identity of each molecule is extrapolated from the pre-established code. In sequential labelling, each RNA is targeted with multiple sequence-specific unicolor probes. Once the sample is imaged, the probes are digested with DNase I, and the next batch of probes with different fluorophores (one per RNA) is hybridized. This will result in a sequential colourcoding, where RNA identities will be assigned using the pre-established code. PCA , principal component analysis; t-SNE, t-distributed stochastic neighbour embedding.
Heterogeneity in cell fate decisions
molecularly primed at an early stage, where the cells are functionally indistinguishable by current methods, or do they become restricted just before their functional segregation? Single-cell transcriptional profiling has addressed this question in the context of the first three lineage-branching points of embryonic development: first, from a totipotent cell to the inner cell mass (ICM) and trophectoderm; second, from the ICM to the epiblast and the primitive endoderm; and third, from the epiblast to the ectoderm, mesoderm and endoderm. In this section, we will discuss recent findings achieved using single-cell experiments to understand these cell fate decisions.
From totipotency to the inner cell mass and trophectoderm. The first lineage segregation in the mouse embryo leads to the generation of the so-called ICM and the trophectoderm (Box 1). This distinction becomes morphologically and molecularly apparent at the blastocyst stage, where cells are divided into round-shaped ICM cells expressing epiblast and primitive endoderm markers, such as the transcription factors Nanog, Oct4 (also known as Pou5f1) and Gata6, and into relatively flat outer trophectoderm cells with high levels of the trophectoderm marker caudal-type homeobox protein 2 (Cdx2) [46] [47] [48] [49] [50] [51] . Although these lineages have been widely characterized, how this segregation occurs remains controversial.
In the past few years, some studies have reported transcriptional heterogeneity between very early blastomeres of many factors that eventually confer the ICM or trophectoderm identity 52, 53 . How this early heterogeneity affects cell fate decisions is currently under debate with two contrasting hypotheses. The equivalence hypothesis argues that individual cells are not pre-patterned until the 8-cell stage, when the embryo undergoes a series of symmetric and asymmetric divisions that drive the internalization of the cells that will become part of the ICM 52, [54] [55] [56] [57] [58] [59] [60] . Under this hypothesis, the heterogeneity seen in early stages is explained as random fluctuations of gene expression. By contrast, the asymmetric hypothesis proposes that partitioning inequities occur during cell divisions, which lead to cellular components being unevenly distributed in the daughter cells [61] [62] [63] [64] [65] . This asymmetry becomes amplified through consecutive divisions and eventually leads to lineage segregation. This hypothesis implies not only that cells would start showing some preferences towards particular lineages before the 8-cell stage but also that this asymmetry would be fairly reproducible between cells when comparing different embryos.
Imaging experiments assessing the behaviour of some ICM and trophectoderm markers, such as Nanog, Oct4 and Cdx2, have shown that these are expressed in a random and uncorrelated manner before lineage segregation is apparent at the 16-cell stage 52 . Although this would support the equivalence hypothesis, these factors could alternatively be essential only once the lineages are established, and some other genes could be responsible for an early cell pre-patterning. To address whether other molecular candidates exist before the 16-cell stage, genome-wide transcriptome analyses are key. Recently, several groups have applied scRNA-seq to cells collected during these stages and have shown that some genes are already expressed in a bimodal manner early on, and that their transcription is positively or negatively intercorrelated, which is unlikely to be compatible with random fluctuations 66, 67 . Gene expression heterogeneity between cells seems to start at the 2-cell stage and increases over time, with significant differences at the 2-to-4 and 4-to-8 cell transitions 53, 66, 67 ( fig. 2a) . Particularly, the transitions where the highest changes in gene expression were observed correspond to the stages where the maternal-to-zygotic transition (MZT) occurs 66, 68 . Since this process consists of the degradation of maternal transcripts and transcription activation of the zygotic genome, it is expected to generate a bimodal distribution of the levels of the transcripts involved. Although the timing of events and some expression profiles differ from mice [69] [70] [71] , similar findings were made in the human setting, where single-cell transcriptomic studies have also shown that the greatest gene expression changes take place during the MZT [70] [71] [72] , supporting the hypothesis that molecular segregation occurs shortly after fertilization.
However, these results do not prove that this transcriptional segregation directly determines cell fates. Of note, recent evidence suggests that the molecular variability seen during earlier stages biases cells towards undergoing either asymmetric or symmetric divisions during the 8-to-16 and 16-to-32-cell stages, which, in turn, would influence cell fate. The transcription factor SRY box 21 (Sox21) was reported to be heterogeneously expressed at the 4-cell stage. When Sox21 was depleted in one of the blastocysts at the 2-cell stage, the probability of the cell to undergo asymmetric divisions was reduced, and the contribution towards the trophectoderm was increased 53 ( fig. 2a) . These results support a model where early transcriptional heterogeneity of some genes influences the type of cell division and cell fate from very early stages. Nevertheless, the evidence provided for these conclusions was indirect, with no direct demonstration that a consistent inter-blastomere segregation of Sox21 mRNA and protein content continues to exist after the 4-cell stage and that this in turn correlates with lineage segregation at the 8-to-16-cell stage. Regarding the question of how asymmetric divisions would then influence cell fate, recent studies have related the fate of daughter cells to different timings of cell division, as well as their exposure to different physical conditions, which then regulate the internalization of the cells that will subsequently become ICM 58, 60, 73 . Such physical conditions include differences in membrane tension, inheritance of the apical pole and contractility of the ICM (reviewed in refS 74, 75 ).
Specification of the inner cell mass to epiblast or primitive endoderm. This first decision, of specification into ICM or trophectoderm, is partly coupled with the second fate choice, where the ICM cells become either epiblast or primitive endoderm. It was first thought that cells become segregated to either lineage depending on their localization within the ICM. However, in 2006, it was demonstrated that cells first become molecularly specified in a 'salt-and-pepper' manner within the ICM Inner cell mass (iCM). group of cells located inside the blastocyst that will give rise to the primitive endoderm and the epiblast.
Trophectoderm group of cells located on the outer part of the blastocyst that will become the supportive extra-embryonic tissues, such as the placenta.
Blastomeres
The cells resulting from the first divisions of the fertilized egg.
Maternal-to-zygotic transition
Process occurring shortly after fertilization, where maternal rNA and proteins are degraded and the zygotic genome is activated and produces rNA and proteins. and later organize themselves to achieve their final configuration: inner epiblast cells surrounded by primitive endoderm 76 . But how is this achieved? How do ICM cells choose between an epiblast and a primitive endoderm identity?
Bimodal distribution
Once at the morula stage (8 cells in the mouse), cells that will form the ICM become internalized during the following two rounds of asymmetric divisions: from 8-to-16 cells and from 16-to-32 cells [57] [58] [59] [60] . Some evidence suggests that the round of division where the ICM cells become internalized influences their epiblast versus primitive endoderm fate 77, 78 (fig. 2b ).
More specifically, cells that internalize during the first round of asymmetric divisions tend to become epiblast whereas a later internalization leads to a higher probability of becoming primitive endoderm. However, whether this is the case has been debated 79 and an alternative mechanism, consisting of a random specification towards epiblast or primitive endoderm, has been proposed ( fig. 2b) . Whichever mechanisms may be at play (see below), singlecell transcriptional studies using sc-qPCR and single-cell microarrays have shown that during early stages, ICM cells are highly heterogeneous and and the trophectoderm (TE). Gene expression differences increase as development progresses. Colours depict gene expression profiles. In the case of the 8-cell, 16-cell and 32-cell stages, colours highlight the type of cell division: symmetric or asymmetric. All the outer cells are trophectoderm, including those produced through asymmetric division (yellow cells). Cells become molecularly heterogeneous at the 2-cell stage, and the molecular segregation is amplified in the offspring, represented as a colour progression along the stages. This molecular segregation leads the blue cells to undergo symmetric divisions and become trophectoderm, while yellow cells divide asymmetrically and give rise to both epiblast (EPI) and primitive endoderm (PE). b | The ordered and random models of the decision between epiblast and primitive endoderm. In the ordered model, the first cells to be internalized at the 16-cell stage will give rise to the epiblast and the later-internalized cells will become the primitive endoderm. In the random model, cells are not specified (purple) until the 32-cell stage. c | The interaction between Nanog + and Gata6 + cells through fibroblast growth factor (FGF) signalling. Nanog represses the transcription factor Gata6 and promotes Fgf4 expression. The resulting Fgf4 emerging from Nanog + cells binds to both fibroblast growth factor receptor 2 (Fgfr2) and Fgfr1 receptors in a paracrine manner in Gata6 + cells and induces the expression of the primitive endoderm transcription factors Gata4 and SRY box 17 (Sox17). At the bottom of the diagram, the transcriptional status of these cells is described, with Nanog + cells being Nanog co-express different epiblast and primitive endoderm markers, which eventually adopt a mutually exclusive pattern 6, 80, 81 . The functions of the transcription factors Nanog and Gata6 and of fibroblast growth factor (FGF) signalling appear to be key to ICM segregation 6, 76, [78] [79] [80] [82] [83] [84] ( fig. 2c ). Single-cell imaging analyses have shown that Nanog and Gata6 become heterogeneously expressed at the 8-to-16-cell stage, with some cells expressing both. Slightly later, these factors are expressed in a mutually exclusive manner, which marks the initiation of lineage segregation 76, 82 . To induce epiblast formation, Nanog activity is required to suppress Gata6 expression 82 . However, the sole expression of Gata6 in Nanog-negative cells is not sufficient to impose the primitive endoderm identity, and FGF signalling is also required 82 . At the 16-to-32-cell stage (E3.25), Fgf4 becomes expressed and secreted by a cell subpopulation that already expresses Nanog and is key for the paracrine induction of the primitive endoderm transcription factors Gata4 and Sox17 in Gata6-expressing cells, thus committing the cells to a primitive endoderm identity 82 .
Notably, a few primitive endoderm-biased cells rarely appear to turn into epiblast cells by re-activating Nanog expression during the initial phases of lineage segregation, indicating that fate change is still possible. Nevertheless, once the epiblast and primitive endoderm fates have been established following FGF signalling, fate switch is absent 81 . Infrequent cell fate switching has also been reported in vitro in ESCs.
Single-cell transcriptome analyses have shown a strong negative correlation between Fgf4 and Fgfr2 expression, suggesting that the direct interaction between fibroblast growth factor 4 (Fgf4) and fibroblast growth factor receptor 2 (Fgfr2) expressed in different cells could be important for the ICM cell fate decision 6, 78, 80, 82 . However, whereas mutations in Fgf4 completely disrupt primitive endoderm formation, mutations in Fgfr2 are not sufficient to abolish this lineage 83, 84 . During these early stages of development, Fgfr1 is also broadly expressed in the ICM, suggesting it has a role in ICM segregation 80 . This hypothesis, which originated from single-cell transcriptional studies, was recently confirmed by two single-cell imaging studies that showed Fgfr1 is required for ICM specification 83, 84 . Thus, the repression of Gata6 by Nanog initiates ICM lineage segregation, and this is subsequently coupled with Fgf4 activity, which completes the epiblast and primitive endoderm specification through its direct interactions with the receptors Fgfr1 and Fgfr2 (fig. 2c ).
Post-implantation epiblast cells: committing to mesendodermal fates.
Once the epiblast and primitive endoderm lineages have segregated, and after the embryo implants into the uterus and undergoes a series of morphological changes (see refS 85, 86 for a review), gastrulation begins (Box 1). During this process, the three germ layers -ectoderm, mesoderm and endoderm -are formed. While mesodermal and endodermal cells arise from epiblast cells ingressing through the primitive streak, the remaining epiblast cells will become the ectoderm 87 .
A series of transplantation assays performed in the 1990s
showed that epiblast cells do not appear to be committed to a specific lineage during this stage; rather, they seem to remain pluripotent and to adopt a particular fate depending on when and where they ingress through the primitive streak 88 . However, fate-mapping studies have shown that cells residing in particular regions within the epiblast have a preference to contribute to a specific tissue 87 . This would suggest that cells are already biased in the epiblast, but, as morphogenetic movements are highly organized at this stage, the starting position rather than any specific transcriptome differences could be the determining factor of epiblast contribution to later-forming tissues.
Post-implantation epiblast cells were recently profiled using single-cell transcriptomics to determine whether they exhibit any priming towards a particular lineage 29, 89 . These studies have shown that post-implantation epiblast cells are molecularly heterogeneous, but they do not appear to express markers indicative of early segregation to mature lineages. Interestingly, however, both studies observed some cells that co-expressed transcription factors known as mesoderm and endoderm markers, such as the T gene (encoding the Brachyury protein) and hepatocyte nuclear factor 3β (also known as Foxa2), indicative of a mesendodermal progenitor identity 90, 91 . This subpopulation seems to appear as early as E5.5 (ref.
89
), when the primitive streak is not morphologically visible, suggesting that it could be one of the earliest cell populations committing towards a mesendodermal fate. Moreover, this also suggests that molecular changes precede morphological changes during gastrulation, although spatial information is needed to confirm this ( fig. 2d) .
Since the E6.5 post-implantation epiblast population appeared to contain the transition from pluripotent epiblast to mesoderm and definitive endoderm, cells were examined for genes whose expression positively or negatively correlated with the expression levels of T 29 . Although some of the resulting dynamically expressed genes have been already reported in the literature, such as the transcription factor Mixl1, these analyses also revealed some potentially novel factors, like solute carrier family 35 member D3, which may have an important role in the generation of mesoderm from epiblast cells. Their further characterization could therefore provide insights into the regulation of epiblast commitment towards the mesendoderm.
Gastrulation
During gastrulation, as the cells ingress through the primitive streak, both the timing and anterior-posterior location along the primitive streak have been shown to influence their lineage fate 85, 88 . The molecular mechanisms establishing this diverse range of progenitors along the streak and the transcription factors regulating mesendodermal cell differentiation towards mature cell types are still obscure, but single-cell transcriptional analyses have contributed to their characterization.
Heterogeneity within the mesodermal population.
To investigate the maturation of a specific lineage from the mesoderm, it is crucial to have a good understanding of the molecular properties of that particular mesodermal progenitor so that we can identify it. Nevertheless,
Primitive streak
Morphological structure at the posterior side of the embryo formed by the accumulation of cells. it is where epiblast cells will ingress to become mesoderm or endoderm.
Mesendodermal progenitor
A cell that can give rise to either mesoderm or endoderm.
assigning a unique combination of markers to define specific progenitor populations has been difficult, and most currently used markers are expressed in several lineages. Functional analyses of progenitor populations defined by ambiguous markers contributed to the attribution of multipotency to mesodermal cells, but a single-cell assessment has revealed that this may not always be the case. For instance, mesodermal cells expressing the kinase vascular endothelial growth factor receptor 2 (VEGFR2; also known as Flk1) can give rise to blood, endothelial and smooth muscle cells [92] [93] [94] ; however, these cells are highly heterogeneous at the molecular level 29 ( fig. 3a) .
Another case is the transcription factor ETS translocation variant 2 (Etv2), which is required for endothelial, endocardial and blood development 95, 96 . Using scRNA-seq, Etv2-expressing cells were shown to be broadly transcriptionally divided into mesodermal, blood, endocardial and endothelial subpopulations, suggesting that, in addition to immature multipotent mesodermal progenitors, unipotent progenitors also exist 97 . The reliance on markers could also be misleading. For instance, during heart development, cardiac cells form two different structures: the first heart field and the second heart field. Both cell populations appear to arise from mesoderm posterior protein 1 (Mesp1)-expressing mesodermal progenitors, but whether a common progenitor or different cardiac progenitors exist that give rise to both fields could not be assessed with population assays 98 . When performing lineage tracing of single clones, each mesodermal clone contributed to either the first heart field or the second heart field, showing that two distinct Mesp1-expressing mesodermal progenitor populations exist 99, 100 . Moreover, sc-qPCR revealed that these populations have different molecular characteristics 100 , suggesting that transcriptional characterization of progenitor populations at the single-cell level will contribute to resolving their heterogeneous differentiation potential.
From mesodermal progenitors to differentiated cell types. Following gastrulation, cells are thought to receive cues that promote changes in gene expression to drive specification towards a particular lineage. To help discover potential regulators of these processes, computational methods were recently applied to gene expression data obtained from individual cells to study the origins of blood cells 10, 19, 29 . During embryonic development, mesodermal progenitors give rise to blood through multiple waves, the first two occurring in the yolk sac ( fig. 3b) .
To investigate the first wave of blood differentiation from mesoderm, single cells expressing Flk1 or CD41, which are proteins expressed during blood development, were profiled using scRNA-seq and, after applying pseudotime inferences, a differentiation trajectory was proposed 29 . Notably, the reconstructed trajectory identified some ChIP-seq-verified target genes of the blooddifferentiation regulator Gata1, such as nuclear factor, erythroid derived 2 (Nfe2), as being upregulated after the onset Gata1 expression, thereby validating the trajectory 29 .
To discover novel factors involved in the emergence of definitive blood within the yolk sac, a Boolean algorithm was applied on sc-qPCR data from cells ranging from uncommitted mesoderm to the appearance of definitive blood in the yolk sac, leading to a model of the underlying gene regulatory network 10 . The produced model predicted the previously unrecognized regulation of Erg by the Hox and Sox transcription factors, which was then experimentally validated. Moreover, it provided a platform for performing in silico perturbations, which predicted the requirement of Sox7 downregulation for blood emergence in the yolk sac during development. This novel finding was also functionally validated using transgenic mouse embryos with enforced Sox7 expression, showing a marked defect in blood maturation. Further characterization of the emergence of definitive blood using single-cell transcriptomics has recently guided the discovery of the leukotriene pathway as a Yolk sac extra-embryonic tissue that originates from the primitive endoderm.
Boolean algorithm
Qualitative algorithm based on the Boolean (binary) logic, where only two values are accepted. in gene regulatory networks, one value will be active and the other one inactive. different colours) . If studied as a whole, these will give rise to blood, endothelium and smooth muscle. However, this progenitor population could be composed of populations of unipotent progenitor cells. b | First and second wave of blood differentiation. The box (left) highlights the region in the yolk sac of mouse embryos at E7.5 where the blood islands can be found. During the first wave of haematopoiesis (zoomed box; left), primitive erythrocytes are apparent in the blood islands at E7.5. During the second wave (zoomed box; right), at around E8.25, the haemogenic endothelium generates erythroid and myeloid progenitors (EMPs), which differentiate into definitive blood cells.
Blood Blood progenitors
previously unrecognized regulator of yolk sac definitive haematopoiesis 19 . Together, these studies demonstrated how single-cell transcriptional measurements not only provide a snapshot of the molecular profiles underlying blood emergence but also enable the prediction of the molecular mechanisms and gene regulatory networks controlling these developmental processes.
Pluripotency in vitro: stem cells
Although in vivo pre-implantation studies have provided insights into how cells become segregated into the epiblast and the primitive endoderm lineages, the transient nature of pluripotent ICM cells limits their use for investigating the molecular process behind the maintenance of, the entry to, and the exit from pluripotency. Understanding this process requires a cell system that is easy to manipulate, able to both self-renew and differentiate, and that also gives the flexibility to follow gene expression dynamics throughout the transition between states.
Defining subpopulations within mouse embryonic stem cells. mESCs have been one of the most popular tools used to understand pluripotency. mESCs were obtained from the ICM in 1981 and were first grown in culture on a feeder cell layer 101 . Advancements in the understanding of their needs led to the two most popular feeder-free culturing strategies, namely, culturing in fetal bovine serum and leukaemia inhibitory factor (serum-LIF) or in 2i, which is a serum-free medium supplemented with the glycogen synthase kinase 3β (GSK3β) and MEK inhibitors (see ref.
102 for a review). DNA methylation profiling as well as single-cell transcriptional studies have shown that mESCs can be divided into at least two major subpopulations: naive pluripotent cells expressing pluripotency factors and epiblast-primed cells, which express higher levels of keratins and actins 24, 39, 103 . Whereas mESCs cultured in serum-LIF are highly heterogeneous, 2i conditions tend to restrict them to a naive state 39, 103, 104 . Nanog is a pluripotency factor that has been widely used to characterize pluripotent states in culture, with high Nanog expression being characteristic of the naive state. Transitions between Nanog-high and Nanoglow populations have been reported, though these are infrequent, which makes the study of the mechanisms behind the entry to and the exit from pluripotency difficult 39, [105] [106] [107] . As seen in vivo, Nanog expression levels also appear to be heterogeneous and dynamic within cell populations grown over time in serum-LIF media, which suggests that cell-state change from the naive to the primed state or vice versa occurs when reaching the lower or upper levels of Nanog expression, respectively. Importantly, this heterogeneity does not seem to be completely random, and a mechanism for cellstate maintenance or switch may exist ( fig. 4a) . Nanog expression appears to correlate with the cell cycle 39, 105, 106 : following cell division, as cells progress through the cell cycle, Nanog levels gradually rise until the next cell division, where they abruptly drop. Transcription noise leading to a higher transcription rate and an extended cell cycle are two nonexclusive hypotheses for increasing Nanog expression to levels that would maintain pluripotency or promote cell-state switch from the primed to the pluripotent state, as both would cause Nanog to gradually accumulate in the cell during consecutive cell cycles 39 ( fig. 4a ). Consistent with this hypothesis, mESCs grown in 2i conditions and composed mostly of cells in the naive state have a higher transcription rate and a longer cell cycle 24, 39 , which would favour the Nanog-high pluripotent state 39, 106 . Recently, single-cell imaging has also enabled the discovery of a rare cell subpopulation within cultured mESCs, presenting some molecular features resembling the embryonic 2-cell (2 C) stage 108 . This 2 C-like population expresses Gag and mouse endogenous retrovirus-L (MERVL), which are two retroviral genes that are transiently expressed in vivo during the 2-cell stage 108 , as well as zinc-finger and SCAN domain containing protein 4 C (Zscan4), which is important for genome stability 109 . Initial single-cell transcriptome profiling clustered the 2 C-like cells with cells from the blastocyst stage instead of with the 2-cell stage 24 . However, a recent single-cell transcriptome re-evaluation has demonstrated that the genes upregulated in the MERVL-expressing and Zscan4-expressing cells are those activated during the MZT, which occurs around the 2-to-4-cell stage 68, 110 . Consistent with being a distinct cell type and in contrast to ESCs or epiblast cells, 2 C-like cells present an open chromatin profile, and their DNA is hypomethylated, thereby resembling the in vivo 2-cell stage 110 . Further supporting their 2-cell identity, 2 C-like cells appear to be totipotent, as they are able to colonize both embryonic and extra-embryonic tissues upon injection into mouse blastocysts 108 .
Induced pluripotent stem cells: reprogramming towards the pluripotent state. The discovery of induced pluripotency by Shinya Yamanaka and colleagues, who reported that the mESC properties of pluripotency and self-renewal can be imparted into mature somatic cells upon overexpression of four transcription factors -Oct4, Sox2, Krüppel-like factor 4 (Klf4) and Myc (OSKM) -has reshaped our understanding of pluripotency regulation 111, 112 . Induced pluripotent stem cells (iPSCs) not only represent a promising technology for regenerative medicine but also constitute a formidable tool to unravel how pluripotency and differentiated lineages are established. Since the seminal reports using retroviral-mediated overexpression of the OSKM factors for iPSC generation 111 , considerable effort has been invested towards improving the initially inefficient rates of cell reprogramming. For example, FACS and mass spectrometry were used to characterize and purify cell-surface marker-defined populations at intermediate stages of reprogramming 113, 114 , but the current proportion of iPSCs produced is still low.
Single-cell qPCR of human and mouse cells has shown that during the early stages of reprogramming, there is an increase in transcriptional heterogeneity within the culture, followed by a gradual decline over time 115, 116 . This initial variation could be attributed to differences in the expression levels of different OSKM factors, as individual cells appear to overexpress the four retroviral constructs at different stoichiometries during the early stages of reprogramming 117 . When evaluating gene expression distributions, dynamically expressed genes tend to start with a bimodal profile at the population level and to later switch to a unimodal distribution 116, 118, 119 . A similar scenario is also seen during the early stages of mESC differentiation 17 , which may suggest that, following external cues, cells start modifying their expression profiles at different rates. This initial heterogeneity has formally been described as a stochastic process, governed by an ordered set of probabilistic events that regulate the expression of each gene independently 115, 116 . Supporting this model, single-cell live imaging and mass cytometry studies have also shown that, upon OSKM expression, cells start dividing at different rates: cells that quickly proliferate and reduce their cellular area are more likely to become iPSCs 120 , whereas those with a lower proliferative profile tend to revert to the original differentiated state 117 ( fig. 4b ). This indicates that the speed of proliferation is a limiting step during the early stages of reprogramming and, therefore, controlling it more precisely may lead to a higher rate of iPSC production.
When studying early stages of reprogramming in more detail, single-cell transcriptomic analysis has shown that changes in the expression of chromatin remodellers are one of the key molecular processes that distinguish cells that will undergo successful reprogramming from those that will fail 116 ( fig. 4b ). This is consistent with previous population studies, where the importance of chromatin remodelling during the first stages of reprogramming had been highlighted (reviewed in ref. 121 ). Once cells become partially reprogrammed during the intermediate stages of the process, non-coding RNAs appear to regulate some of the reprogramming processes, namely, by inducing metabolic changes as well as by suppressing lineage-specific genes, thus suppressing the differentiated phenotype of the cell 111 ( fig. 4b) Here, Nanog levels constantly increase during the cell cycle until reaching level 2 in the y axis. After cell division, the levels return to the initial level 1. Top right: fate switch by increasing the transcription rate. A higher transcription rate will result in higher maximal Nanog levels compared with no fate switch cells (level 4 instead of 2). This results in daughter cells with higher Nanog levels, and the effect is amplified through consecutive cell divisions, leading to cell fate switch towards the naive state when Nanog levels are high enough. Bottom: fate switch by extending the cell cycle. An extension of the cell cycle allows Nanog levels to increase, which again results in a gradual increase in Nanog levels in daughter cells during consecutive cell divisions. b | Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs). The diagram highlights the knowledge of reprogramming acquired using single-cell technologies. Upon induction of reprogramming with the OSKM factors (Oct4, Sry-box 2 (Sox2), Krüppel-like factor 4 (Klf4) and Myc), a stochastic molecular heterogeneity arises in the cell population. Some of the cells undergo fast proliferation, and these will progress to the next step of the reprogramming process. The next step consists of chromatin remodelling followed by repression of differentiated cell fates with non-coding RNAs (ncRNA). The second phase of reprogramming begins with the activation of endogenous Sox2 expression, which triggers the activation of a hierarchical programme of gene expression that finalizes the conversion of the somatic cell into an iPSC.
Unimodal distribution
in gene expression analyses, unimodal distribution refers to a gene being mostly expressed at intermediate levels.
be expressed; however, their expression does not seem to be predictive of successful reprogramming until later on 113, 115 , indicating that the relatively early expression of these factors is not sufficient for iPSC reprogramming. Once the cells enter the late stages of reprogramming, pluripotency factors gain importance. For instance, sc-qPCR has suggested that Sox2 drives a hierarchical sequence of gene expression changes 115 , which finally leads to the cells reaching the iPSC state (fig. 4b ). This sequence of events has not been studied only at the transcriptome level; single-cell high-resolution imaging has also shown that more local transcriptional changes, such as x-chromosome reactivation, also occur in a stepwise manner 122 .
Future perspectives and conclusion One of the greatest challenges of single-cell transcriptomics is the absence of spatial and temporal resolution, which is critically relevant in the context of developmental biology. Computational inferences, such as pseudotime ordering, have contributed to our understanding of defined differentiation trajectories by highlighting potential novel relevant factors and have enabled the analysis of an extensive number of genes compared with current live imaging technologies. However, they are not sufficient to unravel the intricate mechanisms underlying early mammalian development. This is especially relevant once the epiblast and the primitive endoderm are established, as the embryo rapidly acquires a high level of complexity that is orchestrated by dynamic morphogenetic movements, cell proliferation and changes in gene expression, which are difficult to comprehensively capture.
In the past few years, there has been considerable progress in determining spatial positions from singlecell transcriptional data. The establishment of imaging strategies to obtain thousands of single-molecule measurements in single cells has provided us with both real spatial coordinates and quantitative data. Moreover, computational biology has developed algorithms to infer cell positions by reconstructing spatial reference maps from images obtained with fluorescence microscopy 123, 124 . New sample-collection techniques, such as tomo-seq or laser capture microdissection, have also enabled the transcriptomic analysis of particular cells extracted from specific spatial positions 125, 126 . Of note, the latter technique has been recently applied to mouse embryonic development and led to the production of a high-resolution map of E7.0 mouse epiblast cells, which has improved our understanding of the different expression patterns occurring at this developmental stage 127 . Although these techniques are generating promising outcomes, they are laborious and thus require further optimization.
Another area where single-cell technologies are advancing is the development of combined methods to obtain as much information as possible from a single cell. This has currently been implemented at the level of chromatin accessibility, DNA methylation status and the transcriptomic profile 128, 129 , and is expected to give us a mechanistic view of the regulatory systems that govern developmental processes, such as cell differentiation or cell-state transitions. Due to the relatively recent establishment of these techniques, we expect that computational strategies to simultaneously analyse the data will improve in the near future. Moreover, by eliminating the need for reverse transcription and nonspecific amplification, direct sequencing of RNA, which is currently under development for the new generation of nanopore sequencers, also has substantial potential to enhance future scRNA-seq protocols 130 .
One of the main goals of single-cell transcriptomics remains the reconstruction of lineage trajectories using snapshots of continuous developmental processes. Incorporation of lineage tracing strategies into scRNA-seq protocols would therefore provide invaluable evidence to support the lineage hierarchies postulated from scRNA-seq data analyses. Recent studies have attempted to address this challenge by using the CRISPRCas9 genome-editing system to introduce into eukaryotic cells a barcode coupled to a 'scratchpad' sequence harbouring multiple copies of the target sequence of a specific guide RNA 40, 131 . Through successive cell divisions, the Cas9 nuclease will introduce stochastic mutations into the scratchpad sequence, thereby 'recording' the lineage history of the cell and enabling the reconstitution of lineage hierarchies in a given tissue. This powerful technology has been applied in vivo in zebrafish 131 and in vitro in mESC cultures 40 . Coupling this tool to scRNAseq will take the application of single-cell transcriptomics in developmental biology to a whole new level.
Single-cell technologies have already given us many new insights into early mammalian development. Molecular heterogeneity in early embryos as well as in mESCs underscores their highly dynamic nature, but we still do not fully understand the basis for this heterogeneity. We envisage that, in addition to optimization of current methods and the establishment of new techniques, as protocols mature and become more user-friendly, their adoption by the wider developmental biology research community will accelerate and increase their impact. 
X-chromosome reactivation
Process where the inactivated x chromosome in mammalian female cells becomes reactivated.
